Anerning Particle for Reducing the Application of Antibiotics of Childhood Community-acquired Pneumonia: a Randomized, Double Blind, Control of Placebo, Multi-center Clinical Study
试验速览
- 阶段
- 4 期
- 入组人数
- 216
- 主要终点
- Whether Anerning particle can reduce the use of antibiotics
研究概览
简要总结
The purpose of this study is to evaluate the efficacy, safety and whether it can reduction of antibiotic use in the treatment of community-acquired pneumonia in children with Anerning granules combined with ceftriaxone sodium.
详细描述
To evaluate the efficacy, safety and whether it can reduction of antibiotic use in the treatment of community-acquired pneumonia in children with Anerning granules combined with ceftriaxone sodium.In this study, a randomized, double blind, parallel control of placebo, multi-center clinical study will be established. According to the relevant regulations of the CFDA, 216 cases need to be registered at least.The aim population is children who suffering of community-acquired pneumonia from September 2018 to December 2019. These cases will be devided into treatment group（Anerning particle+ Intravenous ceftriaxone sodium）,control group（Anerning particle simulants+ Intravenous ceftriaxone sodium）. Each group will be treated for 10 days hospitalization and if there is adverse drug reaction during treatment, follow-up until the laboratory indicators are normal. The efficacy indicators of this study were mainly from three dimensions: Frequency of antibiotics at the clinical endpoint, Total disease efficiency, Clinical recovery time. The symptom scores changes of each group before and after treatment were observed.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 1 Year 至 5 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Meet the diagnostic criteria for children's CAP Western medicine and consider bacterial infection;
- •Those who meet the diagnostic criteria of TCM syndrome differentiation of wind-heat and closed lung syndrome;
- •Children aged 1 to 5 years old;
- •Within 48 hours of onset of CAP;
- •The informed consent process is in compliance with the regulations, and the legal representative signs the informed consent form.
排除标准
- •Chest X-ray films showed obvious lung tumors and tuberculosis;
- •Those with acute infectious diseases such as measles, whooping cough, and influenza;
- •Other upper respiratory tract infections, wheezing-like bronchitis, bronchial asthma, bronchial foreign bodies and other respiratory diseases;
- •Children with severe malnutrition and immunodeficiency;
- •Combine severe primary diseases such as severe heart, liver, kidney, digestion and hematopoietic system;
- •Those who meet the CAP (severe) Western diagnostic criteria for children;
- •Clinically diagnosed or clinically considered viral pneumonia, Mycoplasma pneumoniae pneumonia;
- •allergic constitution (allergic to more than 2 types of substances), or allergic to penicillins, cephalosporin antibiotics and Anering granules and their components;
- •Researchers believe that it is not appropriate to join the group.
研究组 & 干预措施
treatment group
Anerning particle +ceftriaxone sodium
干预措施: Anerning particle (Drug)
control group
Anerning particle placebo+ceftriaxone sodium
干预措施: control group (Drug)
结局指标
主要结局
Whether Anerning particle can reduce the use of antibiotics
时间窗: After 10 days of medication.When the condition is cured, stop the medicine at any time.
Frequency of antibiotics (DDDs) at clinical endpoints of the two groups
次要结局
- The chest X-ray of 216 participants will be assessed.(The maximum time for administration according to the protocol is 10 days, and the drug can be stopped at any time during clinical cure. If it is not good to change on the 6th day of treatment, use other measures.)
- The blood routine and c-reactive protein of 216 participants will be assessed.(The maximum time for administration according to the protocol is 10 days, and the drug can be stopped at any time during clinical cure. If it is not good to change on the 6th day of treatment, use other measures.)
- Complete fever time(The maximum time for administration according to the protocol is 10 days, and the drug can be stopped at any time during clinical cure. If it is not good to change on the 6th day of treatment, use other measures.)
研究者
Yanming Xie
Deputy director
China Academy of Chinese Medical Sciences